Pharvaris N.V.
PHVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001830487
In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 20 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q1 2024
Institutional positions in Pharvaris N.V. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −1 vs. Q4 2023
- Shares held
- 42.4M
- +1.68M (+4.1%) vs. Q4 2023
- Total value
- $980.5M
- −$162.5M (−14.2%) vs. Q4 2023
- New holders
- 6
- 12 more added
- Sold out
- 7
- 9 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PHVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 125 | $2.23B |
| Q1 2026 | 110 | $1.67B |
| Q4 2025 | 106 | $1.64B |
| Q3 2025 | 83 | $1.44B |
| Q2 2025 | 60 | $792.7M |
| Q1 2025 | 52 | $705.5M |
| Q4 2024 | 54 | $855.8M |
| Q3 2024 | 51 | $834.2M |
| Q2 2024 | 36 | $808.6M |
| Q1 2024 | 35 | $980.5M |
| Q4 2023 | 36 | $1.14B |
| Q3 2023 | 21 | $606.6M |
| Q2 2023 | 21 | $441.6M |
| Q1 2023 | 21 | $173.9M |
| Q4 2022 | 25 | $239.6M |
| Q3 2022 | 21 | $173.6M |
| Q2 2022 | 20 | $494.0M |
| Q1 2022 | 22 | $397.1M |
| Q4 2021 | 22 | $321.1M |
| Q3 2021 | 25 | $380.3M |
| Q2 2021 | 28 | $406.3M |
| Q1 2021 | 33 | $616.5M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Pharvaris N.V.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| General Atlantic LLC | 7,531,252 | $174.0M | 4.04% | +1,375,000+22.3% | Added |
| FMR LLC | 5,192,984 | $120.0M | 0.01% | 00.0% | Unchanged |
| venBio Partners LLC | 4,289,304 | $99.1M | 35.17% | −630,200−12.8% | Reduced |
| Foresite Capital Management IV, LLC | 4,038,842 | $93.3M | 47.16% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 3,653,310 | $84.4M | 0.31% | −3,613−0.1% | Reduced |
| VR Adviser, LLC | 3,395,606 | $78.5M | 3.73% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 3,303,381 | $76.3M | 6.14% | −600,938−15.4% | Reduced |
| Commodore Capital LP | 1,725,000 | $39.9M | 2.67% | +925,000+115.6% | Added |
| Cormorant Asset Management, LP | 1,711,460 | $39.6M | 1.74% | 00.0% | Unchanged |
| Novo Holdings A/S | 1,168,030 | $27.0M | 1.86% | −371,295−24.1% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 1,061,592 | $24.5M | 0.43% | +249,356+30.7% | Added |
| EcoR1 Capital, LLC | 900,000 | $20.8M | 0.53% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 797,600 | $18.4M | 4.13% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 757,915 | $17.5M | 0.00% | −84,783−10.1% | Reduced |
| Rock Springs Capital Management LP | 752,924 | $17.4M | 0.44% | +752,924 | New |
| Sofinnova Investments, Inc. | 584,672 | $13.5M | 0.80% | +74,231+14.5% | Added |
| Soleus Capital Management, L.P. | 401,901 | $9.29M | 0.82% | +184,505+84.9% | Added |
| Sphera Funds Management Ltd. | 392,877 | $9.08M | 1.47% | +147,877+60.4% | Added |
| Citadel Advisors LLC | 238,305 | $5.51M | 0.01% | +96,847+68.5% | Added |
| TD Asset Management Inc | 112,616 | $2.60M | 0.00% | +112,616 | New |
| Walleye Capital LLC | 97,182 | $2.25M | 0.02% | +19,312+24.8% | Added |
| Marshall Wace, LLP | 58,169 | $1.34M | 0.00% | −1,955−3.3% | Reduced |
| Manufacturers Life Insurance Company, The | 55,078 | $1.27M | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 31,224 | $721.6K | 0.00% | +9,629+44.6% | Added |
| Goldman Sachs Group Inc | 31,116 | $719.1K | 0.00% | +22,567+264.0% | Added |
| Qube Research & Technologies Ltd | 30,138 | $696.5K | 0.00% | −2,180−6.7% | Reduced |
| Morgan Stanley | 29,041 | $671.1K | 0.00% | +6,553+29.1% | Added |
| Millennium Management LLC | 20,527 | $474.4K | 0.00% | −167,989−89.1% | Reduced |
| Hudson Bay Capital Management LP | 20,018 | $462.6K | 0.00% | −50,116−71.5% | Reduced |
| HighVista Strategies LLC | 16,750 | $387.1K | 0.14% | +16,750 | New |
| Jump Financial, LLC | 11,700 | $270.4K | 0.01% | +11,700 | New |
| Bank of America Corp | 7,808 | $180.4K | 0.00% | +7,808 | New |
| JPMorgan Chase & Co | 3,150 | $72.8K | 0.00% | +2,960+1,557.9% | Added |
| BlackRock Inc. | 2,268 | $52.4K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 2,000 | $46.2K | 0.01% | +2,000 | New |
| Vivo Capital, LLC | 0 | $0 | 0.00% | −285,000−100.0% | Sold out |
| Blackstone Group Inc. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −18,000−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −12,400−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −8,198−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −750−100.0% | Sold out |
| Piper Sandler & Co. | 0 | $0 | 0.00% | −181−100.0% | Sold out |